Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cibus, Inc. - Class A Common Stock
(NQ:
CBUS
)
2.690
UNCHANGED
Streaming Delayed Price
Updated: 1:00 PM EST, Dec 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Cibus, Inc. - Class A Common Stock
< Previous
1
2
Next >
Cibus, Albaugh LLC and RTDC Company Limited Affirm Collaboration to Enable Commercialization of Cibus’ First Gene Edited Weed Management Solution for U.S. Rice Growers
December 16, 2024
From
Cibus US LLC
Via
GlobeNewswire
Cibus and Biographica Announce Collaboration Using Artificial Intelligence (AI) to Advance Disease Resistance in Canola and Oilseed Rape
November 19, 2024
From
Cibus US LLC; Biographica
Via
GlobeNewswire
Cibus to Participate in the 13th Annual Roth Technology Conference
November 18, 2024
From
Cibus US LLC
Via
GlobeNewswire
Cibus Achieves Additional Milestone for Next Generation Gene Edits for Sclerotinia Resistance in Canola
November 14, 2024
From
Cibus US LLC
Via
GlobeNewswire
Cibus Reports Third Quarter Financial Results and Provides Year-to-Date Business Update for 2024
November 07, 2024
From
Cibus US LLC
Via
GlobeNewswire
Cibus Confirms its Herbicide Tolerance (HT2) Trait Shows Increased Tolerance to a Novel Herbicide for Weed Control in Canola
November 05, 2024
From
Cibus US LLC
Via
GlobeNewswire
Cibus to Report Third Quarter 2024 Financial Results on November 7, 2024 After the Market Close and Host Conference Call
October 24, 2024
From
Cibus US LLC
Via
GlobeNewswire
Cibus Inc. Announces Realigned Organization to Advance its Commercial Opportunities
October 21, 2024
Projected Cost Savings of Approximately $10 Million on Annualized Run-Rate Basis and Expected to Reduce Cash Use by Approximately 20%
From
Cibus US LLC
Via
GlobeNewswire
Cibus Technology to be Featured on InnovAction Stage at the Euroseeds2024 Congress
October 11, 2024
From
Cibus US LLC
Via
GlobeNewswire
Cibus to Participate in the Food+ Forum during the 79th Session of the United Nations General Assembly
September 23, 2024
From
Cibus US LLC
Via
GlobeNewswire
Cibus Announces Pricing of Public Offering of Class A Common Stock
September 18, 2024
From
Cibus US LLC
Via
GlobeNewswire
Cibus, Inc. Announces Proposed Public Offering of Class A Common Stock
September 17, 2024
From
Cibus US LLC
Via
GlobeNewswire
Cibus Completes First Field Trials in UK for Pod Shatter Reduction in Winter Oilseed Rape
September 10, 2024
From
Cibus US LLC
Via
GlobeNewswire
Cibus to Participate in Upcoming August Investor Events
August 12, 2024
From
Cibus US LLC
Via
GlobeNewswire
Cibus Reports Second Quarter Financial Results and Provides First Half Business Update
August 08, 2024
From
Cibus US LLC
Via
GlobeNewswire
Cibus Achieves Positive Initial Field Trial Results for Stacked Gene Edited Herbicide Tolerant Traits in Rice
August 06, 2024
From
Cibus US LLC
Via
GlobeNewswire
Cibus to Report Second Quarter 2024 Financial Results on August 8, 2024 After the Market Close and Host Conference Call
August 01, 2024
From
Cibus US LLC
Via
GlobeNewswire
Cibus Expands its Intellectual Property Coverage for Plant Gene Editing and Traits
June 26, 2024
From
Cibus US LLC
Via
GlobeNewswire
Cibus' Confirms Important Milestone for Nutrient Use Efficiency Trait Development
June 17, 2024
From
Cibus US LLC
Via
GlobeNewswire
Cibus Announces $13.0 Million Registered Direct Offering
June 12, 2024
From
Cibus US LLC
Via
GlobeNewswire
CIBUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Cibus, Inc. on Behalf of Cibus Stockholders and Encourages Investors to Contact the Firm
June 06, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Cibus, Inc. (CBUS) on Behalf of Investors
June 05, 2024
From
Glancy Prongay & Murray LLP
Via
Business Wire
Cibus to Participate in Upcoming June Investor Events
June 05, 2024
From
Cibus US LLC
Via
GlobeNewswire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Cibus, Inc. (CBUS) on Behalf of Investors
June 04, 2024
From
Law Offices of Howard G. Smith
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Cibus, Inc. (CBUS) on Behalf of Investors
June 04, 2024
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Cibus’ White Mold (Sclerotinia) Resistance Trait Program Confirms Important Milestone for Next Generation Gene Edits in Canola
May 30, 2024
From
Cibus US LLC
Via
GlobeNewswire
Canada Added to a Growing List of Countries Regulating Cibus’ Gene Editing Technologies Similar to Conventional Breeding
May 15, 2024
Cibus Applauds the Canadian Food Inspection Agency’s (CFIA) New Guidelines for Plants Developed Using Gene Editing
From
Cibus US LLC
Via
GlobeNewswire
Cibus to Participate in the BMO Global Farm to Market Conference
May 13, 2024
From
Cibus US LLC
Via
GlobeNewswire
Cibus Reports First Quarter Financial Results and Provides Business Update
May 09, 2024
From
Cibus US LLC
Via
GlobeNewswire
Cibus to Report First Quarter 2024 Financial Results on May 9, 2024 and Host Conference Call
April 25, 2024
From
Cibus US LLC
Via
GlobeNewswire
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.